Physician
Borschel, Dawn
Borschel, Dawn was paid $1.07M by Medicaid between Feb 2018 and Dec 2024, across 29 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 51% of everything it billed.
33Billing provider infoBORSCHEL, DAWN
PAWTUCKET, RI 02860
PAWTUCKET, RI 02860
33aNPI1124002365assigned 12/01/2005
33bProvider typeFamily Medicine Physician
28Total paid$1.07M
24GClaims12,808
24DCodes billed29
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Rhode Island
Rank by total paid#5 of 220
Median peer was paid$33K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,375 | $141K | |
| 2019 | 992 | $131K | |
| 2020 | 3,491 | $224K | |
| 2021 | 3,813 | $277K | |
| 2022 | 1,724 | $171K | |
| 2023 | 740 | $61K | |
| 2024incomplete | 673 | $60K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 51% | 3,207 | 2,935 | $548K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 2,127 | 2,002 | $193K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 2,886 | 2,744 | $181K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 342 | 320 | $30K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.6% | 686 | 637 | $28K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.5% | 90 | 89 | $16K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.4% | 267 | 248 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.3% | 230 | 222 | $14K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 194 | 181 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 165 | 155 | $7K |
| 80061 | Lipid panel | <1% | 113 | 109 | $7K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 127 | 123 | $6K |
17 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 55 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 105 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 39 | $3K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 83 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 44 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14 | $805.48 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 13 | $576.91 |
| 81025 | <1% | 12 | $426.81 | |
| 3078F | <1% | 606 | $1.00 | |
| 1036F | <1% | 499 | $0.70 | |
| 3074F | <1% | 428 | $0.20 | |
| 3079F | <1% | 139 | $0.19 | |
| 90686 | <1% | 16 | $0.16 | |
| 3077F | <1% | 103 | $0.16 | |
| 4010F | <1% | 128 | $0.14 | |
| 4004F | <1% | 14 | $0.09 | |
| 3075F | <1% | 76 | $0.03 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.